ScanSource (SCSC) Financials

$41.36 -0.16 (-0.39%)

As of 06/12/2025 04:00 PM Eastern

Annual Income Statements for ScanSource

This table shows ScanSource's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	6/30/2022	6/30/2023	6/30/2024
Net Income / (Loss) Attributable to Common Shareholders	89	90	77
Consolidated Net Income / (Loss)	89	90	77
Net Income / (Loss) Continuing Operations	89	88	77
Total Pre-Tax Income	119	122	100
Total Operating Income	122	136	90
Total Gross Profit	427	449	399
Total Revenue	3,530	3,788	3,260
Operating Revenue	3,530	3,788	3,260
Total Cost of Revenue	3,103	3,338	2,861
Operating Cost of Revenue	3,103	3,338	2,861
Total Operating Expenses	304	313	309
Selling, General & Admin Expense	275	286	277
Depreciation Expense	11	11	11
Amortization Expense	18	17	16
Restructuring Charge	0.00	0.00	4.36
Total Other Income / (Expense), net	-3.54	-14	9.52
Interest Expense	6.52	20	13
Interest & Investment Income	4.33	7.41	9.38
Other Income / (Expense), net	-1.35	-1.66	13
Income Tax Expense	30	34	23
Net Income / (Loss) Discontinued Operations	0.10	1.72	0.00
Basic Earnings per Share	$3.48	$3.57	$3.10
Weighted Average Basic Shares Outstanding	25.50M	25.14M	24.87M
Diluted Earnings per Share	$3.45	$3.54	$3.06
Weighted Average Diluted Shares Outstanding	25.76M	25.36M	25.22M
Weighted Average Basic & Diluted Shares Outstanding	25.19M	24.84M	24.03M

This table shows ScanSource's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	24	26	21	19	15	33	13	16	17	17	17
Consolidated Net Income / (Loss)	24	26	21	19	15	33	13	16	17	17	17
Net Income / (Loss) Continuing Operations	24	26	21	17	15	33	13	16	17	17	17
Total Pre-Tax Income	32	36	30	23	19	40	18	23	23	20	24
Total Operating Income	35	39	34	27	24	27	18	22	18	18	22
Total Gross Profit	113	115	112	109	107	101	94	97	102	102	100
Total Revenue	944	1,011	886	947	876	885	753	746	776	747	705
Operating Revenue	944	1,011	886	947	876	885	753	746	776	747	705
Total Cost of Revenue	830	896	774	838	770	784	658	649	674	646	605
Operating Cost of Revenue	830	896	774	838	770	784	658	649	674	646	605
Total Operating Expenses	79	76	77	81	82	74	77	75	84	83	78
Selling, General & Admin Expense	72	69	71	74	75	67	67	68	72	74	70
Depreciation Expense	2.76	2.68	2.64	2.83	2.80	2.96	2.69	2.77	2.86	2.90	2.32
Amortization Expense	4.24	4.15	4.17	4.19	4.19	4.04	3.75	3.74	4.36	5.00	4.94
Restructuring Charge	-	-	0.00	-	0.00	0.00	3.92	-	5.07	0.31	0.00
Other Special Charges / (Income)	-	-	-	-	-	0.00	-	-	-	1.14	0.90
Total Other Income / (Expense), net	-2.61	-3.24	-4.37	-3.83	-4.94	13	0.41	0.82	5.33	1.27	1.89
Interest Expense	3.45	5.06	5.72	5.56	5.59	3.36	2.00	2.09	2.11	1.97	1.84
Interest & Investment Income	1.59	2.03	1.71	2.09	1.33	2.12	2.65	3.29	2.66	2.69	2.84
Other Income / (Expense), net	-0.75	-0.21	-0.36	-0.35	-0.68	14	-0.24	-0.38	4.78	0.54	0.88
Income Tax Expense	8.24	10	8.69	6.37	3.72	7.32	5.15	6.60	5.99	2.66	6.80
Basic Earnings per Share	$0.95	$1.02	$0.84	$0.76	$0.62	$1.31	$0.51	$0.66	$0.70	$0.72	$0.75
Weighted Average Basic Shares Outstanding	25.20M	25.29M	25.20M	25.14M	24.89M	25.04M	25.03M	24.87M	24.15M	23.81M	23.28M
Diluted Earnings per Share	$0.94	$1.01	$0.83	$0.76	$0.61	$1.29	$0.50	$0.66	$0.69	$0.70	$0.74
Weighted Average Diluted Shares Outstanding	25.45M	25.50M	25.44M	25.36M	25.18M	25.33M	25.44M	25.22M	24.65M	24.22M	23.60M
Weighted Average Basic & Diluted Shares Outstanding	25.25M	25.35M	24.90M	24.84M	24.97M	25.17M	24.71M	24.03M	0.00	23.46M	22.60M

This table details how cash moves in and out of ScanSource's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	6/30/2022	6/30/2023	6/30/2024
Net Change in Cash & Equivalents	-25	-1.81	149
Net Cash From Operating Activities	-124	-36	372
Net Cash From Continuing Operating Activities	-124	-36	372
Net Income / (Loss) Continuing Operations	89	88	77
Consolidated Net Income / (Loss)	89	90	77
Net Income / (Loss) Discontinued Operations	0.10	1.72	0.00
Depreciation Expense	30	29	28
Amortization Expense	0.42	0.58	0.39
Non-Cash Adjustments To Reconcile Net Income	13	14	3.80
Changes in Operating Assets and Liabilities, net	-257	-167	262
Net Cash From Discontinued Operating Activities	0.00	0.00	0.00
Net Cash From Investing Activities	-3.72	-8.26	9.05
Net Cash From Continuing Investing Activities	-3.72	-8.26	9.05
Purchase of Property, Plant & Equipment	-6.85	-9.98	-8.56
Divestitures	3.13	1.72	18
Net Cash From Discontinued Investing Activities	0.00	0.00	0.00
Net Cash From Financing Activities	108	40	-228
Net Cash From Continuing Financing Activities	108	40	-228
Repayment of Debt	-2,040	-2,442	-1,447
Repurchase of Common Equity	-18	-16	-43
Issuance of Debt	2,166	2,499	1,260
Other Financing Activities, net	-0.45	-1.55	1.94
Net Cash From Discontinued Financing Activities	0.00	0.00	0.00
Effect of Exchange Rate Changes	-4.76	2.69	-3.64
Cash Interest Paid	6.07	19	13
Cash Income Taxes Paid	29	29	27

This table details how cash moves in and out of ScanSource's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Change in Cash & Equivalents	2.49	26	-29	-1.20	6.47	2.34	114	26	-40	-35	36
Net Cash From Operating Activities	-48	-27	55	-15	94	63	160	55	45	-6.19	66
Net Cash From Continuing Operating Activities	-48	-27	55	-15	94	63	160	55	45	-6.19	66
Net Income / (Loss) Continuing Operations	24	26	21	17	15	33	13	16	17	17	17
Consolidated Net Income / (Loss)	24	26	21	19	15	33	13	16	17	17	17
Depreciation Expense	7.23	7.06	7.07	7.26	7.22	7.26	6.74	6.79	7.47	8.13	7.49
Amortization Expense	0.29	0.10	0.10	0.10	0.10	0.10	0.10	0.10	0.10	0.10	0.10
Non-Cash Adjustments To Reconcile Net Income	2.44	3.29	4.78	3.53	6.94	-12	3.80	4.67	4.17	7.29	4.69
Changes in Operating Assets and Liabilities, net	-82	-63	22	-43	64	35	137	27	16	-39	36
Net Cash From Investing Activities	-0.68	-3.58	-2.29	-1.71	-2.32	15	-2.42	-1.65	-59	0.77	-1.42
Net Cash From Continuing Investing Activities	-0.68	-3.58	-2.29	-1.71	-2.32	15	-2.42	-1.65	-59	0.77	-1.42
Purchase of Property, Plant & Equipment	-0.68	-3.58	-2.29	-3.43	-2.32	-2.55	-2.42	-1.27	-2.38	-1.97	-1.42
Net Cash From Financing Activities	53	55	-82	14	-83	-78	-43	-24	-27	-26	-31
Net Cash From Continuing Financing Activities	53	55	-82	14	-83	-78	-43	-24	-27	-26	-31
Repayment of Debt	-525	-597	-712	-608	-671	-626	-131	-19	-9.06	-22	-14
Repurchase of Common Equity	-	-	-11	-4.93	0.00	-1.25	-20	-22	-28	-24	-29
Issuance of Debt	579	653	640	627	589	546	108	17	8.38	18	12
Other Financing Activities, net	-0.59	-1.11	0.12	0.03	-1.51	3.16	0.18	0.11	2.18	2.51	0.00
Effect of Exchange Rate Changes	-1.34	1.38	0.84	1.81	-1.26	1.50	-1.03	-2.86	0.61	-3.38	2.19

This table presents ScanSource's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	6/30/2022	6/30/2023	6/30/2024
Total Assets	1,937	2,068	1,779
Total Current Assets	1,524	1,657	1,405
Cash & Equivalents	38	36	185
Accounts Receivable	729	753	582
Inventories, net	615	758	513
Prepaid Expenses	142	110	125
Plant, Property, & Equipment, net	0.00	0.00	34
Total Noncurrent Assets	414	411	341
Goodwill	214	217	206
Intangible Assets	84	68	38
Noncurrent Deferred & Refundable Income Taxes	16	18	20
Other Noncurrent Operating Assets	99	108	77
Total Liabilities & Shareholders' Equity	1,937	2,068	1,779
Total Liabilities	1,131	1,163	855
Total Current Liabilities	814	787	669
Short-Term Debt	12	6.92	7.86
Accounts Payable	714	691	588
Current Deferred & Payable Income Tax Liabilities	0.03	9.88	7.90
Other Current Liabilities	88	79	66
Total Noncurrent Liabilities	317	376	185
Long-Term Debt	260	323	136
Other Noncurrent Operating Liabilities	54	49	49
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	807	905	924
Total Preferred & Common Equity	807	905	924
Preferred Stock	0.00	0.00	0.00
Total Common Equity	807	905	924
Common Stock	64	58	26
Retained Earnings	847	937	1,014
Accumulated Other Comprehensive Income / (Loss)	-105	-90	-116

This table presents ScanSource's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	9/30/2023	12/31/2023	3/31/2024	9/30/2024	12/31/2024	3/31/2025
Total Assets	2,000	2,131	1,980	1,899	1,781	1,783	1,787	1,703	1,725
Total Current Assets	1,588	1,719	1,578	1,507	1,405	1,416	1,352	1,284	1,310
Cash & Equivalents	40	66	37	43	45	159	145	111	146
Accounts Receivable	745	780	684	692	663	590	567	549	563
Inventories, net	676	762	753	656	575	529	504	492	476
Prepaid Expenses	126	111	103	117	122	138	136	132	125
Plant, Property, & Equipment, net	0.00	0.00	36	0.00	0.00	36	33	30	30
Total Noncurrent Assets	413	411	366	391	376	331	401	389	385
Goodwill	212	214	215	215	208	208	233	228	229
Intangible Assets	79	76	72	64	45	42	78	73	68
Noncurrent Deferred & Refundable Income Taxes	13	15	14	16	19	19	17	18	18
Other Noncurrent Operating Assets	109	106	65	96	103	63	73	70	70
Total Liabilities & Shareholders' Equity	2,000	2,131	1,980	1,899	1,781	1,783	1,787	1,703	1,725
Total Liabilities	1,173	1,268	1,101	983	827	839	866	802	823
Total Current Liabilities	794	837	744	701	611	643	666	610	632
Short-Term Debt	4.10	5.04	5.98	8.21	7.86	7.86	12	9.90	9.60
Accounts Payable	711	749	657	618	541	556	579	520	541
Current Deferred & Payable Income Tax Liabilities	5.27	6.05	4.44	8.11	3.65	4.79	6.38	8.33	13
Other Current Liabilities	74	77	77	67	58	75	69	71	68
Total Noncurrent Liabilities	379	431	357	282	217	196	200	192	192
Long-Term Debt	322	378	305	240	161	138	134	132	130
Other Noncurrent Operating Liabilities	54	51	49	39	56	58	66	60	61
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	827	862	879	915	954	944	921	901	902
Total Preferred & Common Equity	827	862	879	915	954	944	921	901	902
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	827	862	879	915	954	944	921	901	902
Common Stock	66	68	60	60	64	46	2.98	0.00	0.00
Retained Earnings	871	897	918	952	985	998	1,031	1,032	1,023
Accumulated Other Comprehensive Income / (Loss)	-110	-103	-99	-96	-95	-100	-113	-131	-122

This table displays calculated financial ratios and metrics derived from ScanSource's official financial filings.

Metric	2022	2023	2024
Period end date	6/30/2022	6/30/2023	6/30/2024
Growth Metrics	-	-	-
Revenue Growth	12.03%	7.30%	-13.94%
EBITDA Growth	58.58%	8.14%	-19.29%
EBIT Growth	96.87%	11.10%	-22.90%
NOPAT Growth	88.33%	7.54%	-29.04%
Net Income Growth	722.58%	1.14%	-14.20%
EPS Growth	721.43%	2.61%	-13.56%
Operating Cash Flow Growth	-206.50%	71.24%	1,139.02%
Free Cash Flow Firm Growth	-240.26%	55.33%	731.87%
Invested Capital Growth	28.10%	15.32%	-26.37%
Revenue Q/Q Growth	3.20%	-0.40%	-5.81%
EBITDA Q/Q Growth	2.03%	-0.16%	-4.28%
EBIT Q/Q Growth	2.89%	0.15%	-4.99%
NOPAT Q/Q Growth	-0.06%	-1.05%	-6.15%
Net Income Q/Q Growth	-4.07%	-1.25%	-3.40%
EPS Q/Q Growth	-4.43%	-0.56%	-3.16%
Operating Cash Flow Q/Q Growth	-893.38%	63.94%	23.21%
Free Cash Flow Firm Q/Q Growth	-942.69%	43.81%	30.38%
Invested Capital Q/Q Growth	10.07%	4.03%	-5.16%
Profitability Metrics	-	-	-
Gross Margin	12.08%	11.86%	12.24%
EBITDA Margin	4.28%	4.31%	4.05%
Operating Margin	3.46%	3.59%	2.77%
EBIT Margin	3.42%	3.54%	3.17%
Profit (Net Income) Margin	2.52%	2.37%	2.36%
Tax Burden Percent	74.86%	73.70%	77.18%
Interest Burden Percent	98.19%	90.78%	96.47%
Effective Tax Rate	25.23%	27.70%	22.82%
Return on Invested Capital (ROIC)	9.87%	8.78%	6.70%
ROIC Less NNEP Spread (ROIC-NNEP)	8.24%	5.58%	12.52%
Return on Net Nonoperating Assets (RNNOA)	1.68%	1.72%	1.73%
Return on Equity (ROE)	11.55%	10.49%	8.42%
Cash Return on Invested Capital (CROIC)	-14.77%	-5.46%	37.07%
Operating Return on Assets (OROA)	6.69%	6.70%	5.38%
Return on Assets (ROA)	4.92%	4.48%	4.01%
Return on Common Equity (ROCE)	11.55%	10.49%	8.42%
Return on Equity Simple (ROE_SIMPLE)	11.01%	9.92%	8.34%
Net Operating Profit after Tax (NOPAT)	91	98	70
NOPAT Margin	2.59%	2.59%	2.14%
Net Nonoperating Expense Percent (NNEP)	1.63%	3.20%	-5.82%
Cost of Revenue to Revenue	87.92%	88.14%	87.76%
SG&A Expenses to Revenue	7.80%	7.54%	8.51%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	8.62%	8.27%	9.47%
Earnings before Interest and Taxes (EBIT)	121	134	103
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	151	163	132
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	0.97	0.81	1.18
Price to Tangible Book Value (P/TBV)	1.55	1.19	1.61
Price to Revenue (P/Rev)	0.22	0.19	0.34
Price to Earnings (P/E)	8.85	8.20	14.21
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	11.30%	12.20%	7.04%
Enterprise Value to Invested Capital (EV/IC)	0.98	0.86	1.19
Enterprise Value to Revenue (EV/Rev)	0.29	0.27	0.32
Enterprise Value to EBITDA (EV/EBITDA)	6.74	6.30	7.99
Enterprise Value to EBIT (EV/EBIT)	8.43	7.67	10.18
Enterprise Value to NOPAT (EV/NOPAT)	11.15	10.48	15.11
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	2.83
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	2.73
Leverage & Solvency	-	-	-
Debt to Equity	0.34	0.36	0.16
Long-Term Debt to Equity	0.32	0.36	0.15
Financial Leverage	0.20	0.31	0.14
Leverage Ratio	2.35	2.34	2.10
Compound Leverage Factor	2.30	2.12	2.03
Debt to Total Capital	25.16%	26.71%	13.48%
Short-Term Debt to Total Capital	1.08%	0.56%	0.74%
Long-Term Debt to Total Capital	24.09%	26.15%	12.74%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	74.84%	73.29%	86.52%
Debt to EBITDA	1.79	2.02	1.09
Net Debt to EBITDA	1.54	1.80	-0.31
Long-Term Debt to EBITDA	1.72	1.98	1.03
Debt to NOPAT	2.97	3.36	2.07
Net Debt to NOPAT	2.55	2.99	-0.59
Long-Term Debt to NOPAT	2.84	3.29	1.95
Altman Z-Score	3.50	3.56	4.09
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	1.87	2.11	2.10
Quick Ratio	0.94	1.00	1.15
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-137	-61	386
Operating Cash Flow to CapEx	-1,815.65%	-358.44%	4,344.21%
Free Cash Flow to Firm to Interest Expense	-20.96	-3.09	29.61
Operating Cash Flow to Interest Expense	-19.06	-1.81	28.52
Operating Cash Flow Less CapEx to Interest Expense	-20.11	-2.31	27.86
Efficiency Ratios	-	-	-
Asset Turnover	1.96	1.89	1.69
Accounts Receivable Turnover	5.44	5.11	4.88
Inventory Turnover	5.72	4.87	4.50
Fixed Asset Turnover	0.00	0.00	0.00
Accounts Payable Turnover	4.60	4.75	4.47
Days Sales Outstanding (DSO)	67.13	71.44	74.73
Days Inventory Outstanding (DIO)	63.80	75.02	81.03
Days Payable Outstanding (DPO)	79.33	76.82	81.60
Cash Conversion Cycle (CCC)	51.60	69.64	74.16
Capital & Investment Metrics	-	-	-
Invested Capital	1,040	1,199	883
Invested Capital Turnover	3.81	3.38	3.13
Increase / (Decrease) in Invested Capital	228	159	-316
Enterprise Value (EV)	1,019	1,030	1,053
Market Capitalization	786	736	1,095
Book Value per Share	$31.96	$36.36	$37.41
Tangible Book Value per Share	$20.12	$24.90	$27.53
Total Capital	1,078	1,235	1,068
Total Debt	271	330	144
Total Long-Term Debt	260	323	136
Net Debt	233	294	-41
Capital Expenditures (CapEx)	6.85	9.98	8.56
Debt-free, Cash-free Net Working Capital (DFCFNWC)	683	841	558
Debt-free Net Working Capital (DFNWC)	721	877	743
Net Working Capital (NWC)	710	870	735
Net Nonoperating Expense (NNE)	2.55	8.43	-7.35
Net Nonoperating Obligations (NNO)	233	294	-41
Total Depreciation and Amortization (D&A)	30	29	28
Debt-free, Cash-free Net Working Capital to Revenue	19.35%	22.20%	17.11%
Debt-free Net Working Capital to Revenue	20.43%	23.16%	22.80%
Net Working Capital to Revenue	20.10%	22.98%	22.56%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$3.48	$3.57	$3.10
Adjusted Weighted Average Basic Shares Outstanding	25.50M	25.14M	24.87M
Adjusted Diluted Earnings per Share	$3.45	$3.54	$3.06
Adjusted Weighted Average Diluted Shares Outstanding	25.76M	25.36M	25.22M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	25.19M	24.84M	24.03M
Normalized Net Operating Profit after Tax (NOPAT)	91	98	73
Normalized NOPAT Margin	2.59%	2.59%	2.24%
Pre Tax Income Margin	3.36%	3.22%	3.06%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	18.52	6.78	7.94
NOPAT to Interest Expense	14.00	4.97	5.35
EBIT Less CapEx to Interest Expense	17.47	6.28	7.29
NOPAT Less CapEx to Interest Expense	12.95	4.46	4.69
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	20.50%	17.43%	55.66%

This table displays calculated financial ratios and metrics derived from ScanSource's official financial filings.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	10.06%	17.03%	4.67%	-1.57%	-7.15%	-12.50%	-15.01%	-21.23%	-11.49%	-15.52%	-6.34%
EBITDA Growth	10.15%	21.13%	1.55%	-0.74%	-26.26%	4.88%	-41.25%	-17.21%	-2.41%	-44.05%	27.63%
EBIT Growth	13.56%	26.72%	2.62%	0.74%	-31.44%	5.25%	-48.99%	-20.20%	-4.25%	-54.01%	34.22%
NOPAT Growth	14.23%	16.92%	2.28%	-4.73%	-25.29%	-21.81%	-48.54%	-21.98%	-32.86%	-27.21%	28.45%
Net Income Growth	8.92%	10.67%	-9.80%	-5.69%	-35.81%	27.17%	-39.65%	-14.44%	9.99%	-47.89%	36.12%
EPS Growth	9.30%	12.22%	-8.79%	-2.56%	-35.11%	27.72%	-39.76%	-13.16%	13.11%	-45.74%	48.00%
Operating Cash Flow Growth	14.92%	-45.97%	84.60%	80.60%	293.01%	335.15%	192.04%	458.69%	-52.07%	-109.79%	-58.75%
Free Cash Flow Firm Growth	-173.12%	-56.28%	-127.46%	32.71%	105.86%	156.24%	227.53%	337.89%	1,720.44%	30.56%	-77.91%
Invested Capital Growth	25.34%	26.57%	22.02%	15.32%	0.70%	-8.61%	-19.23%	-26.37%	-17.78%	-13.48%	-3.83%
Revenue Q/Q Growth	-1.92%	7.14%	-12.43%	6.96%	-7.48%	0.97%	-14.94%	-0.86%	3.95%	-3.62%	-5.71%
EBITDA Q/Q Growth	20.60%	11.33%	-11.41%	-16.55%	-10.41%	58.34%	-50.37%	17.59%	5.61%	-9.22%	13.20%
EBIT Q/Q Growth	27.68%	14.89%	-13.53%	-20.58%	-13.10%	76.38%	-58.09%	24.25%	4.26%	-15.28%	22.30%
NOPAT Q/Q Growth	24.50%	7.91%	-13.27%	-18.24%	-2.37%	12.94%	-42.92%	23.96%	-15.98%	22.45%	0.72%
Net Income Q/Q Growth	20.53%	7.04%	-17.54%	-11.35%	-17.97%	112.07%	-60.87%	25.69%	5.45%	0.47%	2.22%
EPS Q/Q Growth	20.51%	7.45%	-17.82%	-8.43%	-19.74%	111.48%	-61.24%	32.00%	4.55%	1.45%	5.71%
Operating Cash Flow Q/Q Growth	38.41%	44.52%	303.96%	-127.83%	712.89%	-32.40%	153.31%	-65.82%	-18.10%	-113.80%	1,167.58%
Free Cash Flow Firm Q/Q Growth	3.94%	-10.25%	16.31%	24.08%	108.37%	958.05%	89.78%	41.62%	-35.98%	-24.12%	-67.89%
Invested Capital Q/Q Growth	7.05%	5.91%	-2.22%	4.03%	-6.53%	-3.88%	-13.59%	-5.16%	4.37%	1.16%	-3.95%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	12.02%	11.41%	12.62%	11.47%	12.15%	11.39%	12.55%	13.04%	13.10%	13.61%	14.22%
EBITDA Margin	4.41%	4.59%	4.64%	3.62%	3.51%	5.50%	3.21%	3.80%	3.87%	3.64%	4.37%
Operating Margin	3.70%	3.90%	3.87%	2.88%	2.75%	3.03%	2.33%	2.93%	2.27%	2.47%	3.17%
EBIT Margin	3.62%	3.88%	3.83%	2.84%	2.67%	4.67%	2.30%	2.88%	2.89%	2.54%	3.29%
Profit (Net Income) Margin	2.55%	2.54%	2.40%	1.99%	1.76%	3.70%	1.70%	2.16%	2.19%	2.28%	2.47%
Tax Burden Percent	74.47%	71.10%	70.94%	80.18%	80.60%	81.72%	71.33%	70.92%	73.92%	86.52%	71.95%
Interest Burden Percent	94.56%	92.27%	88.19%	87.10%	81.80%	97.00%	103.76%	105.58%	102.45%	103.81%	104.33%
Effective Tax Rate	25.53%	28.90%	29.06%	27.14%	19.40%	18.28%	28.67%	29.08%	26.08%	13.48%	28.05%
Return on Invested Capital (ROIC)	9.95%	9.89%	9.96%	7.10%	7.38%	7.89%	5.52%	6.51%	5.20%	6.42%	7.43%
ROIC Less NNEP Spread (ROIC-NNEP)	9.04%	8.93%	8.45%	6.70%	5.76%	12.80%	5.75%	6.97%	9.03%	7.83%	-6.36%
Return on Net Nonoperating Assets (RNNOA)	2.46%	2.62%	2.06%	2.06%	1.62%	3.10%	0.82%	0.96%	1.01%	0.66%	0.07%
Return on Equity (ROE)	12.41%	12.51%	12.02%	9.16%	9.00%	11.00%	6.35%	7.47%	6.21%	7.08%	7.50%
Cash Return on Invested Capital (CROIC)	-13.04%	-14.10%	-10.36%	-5.46%	7.49%	16.66%	28.41%	37.07%	25.75%	20.12%	10.54%
Operating Return on Assets (OROA)	7.08%	7.48%	7.62%	5.38%	5.10%	8.57%	4.23%	4.88%	4.95%	4.41%	5.59%
Return on Assets (ROA)	4.98%	4.91%	4.77%	3.76%	3.36%	6.80%	3.13%	3.66%	3.75%	3.96%	4.19%
Return on Common Equity (ROCE)	12.41%	12.51%	12.02%	9.16%	9.00%	11.00%	6.35%	7.47%	6.21%	7.08%	7.50%
Return on Equity Simple (ROE_SIMPLE)	10.98%	10.81%	10.35%	0.00%	8.87%	9.25%	8.45%	0.00%	8.54%	6.99%	7.49%
Net Operating Profit after Tax (NOPAT)	26	28	24	20	19	22	13	16	13	16	16
NOPAT Margin	2.75%	2.77%	2.75%	2.10%	2.22%	2.48%	1.66%	2.08%	1.68%	2.13%	2.28%
Net Nonoperating Expense Percent (NNEP)	0.91%	0.96%	1.50%	0.41%	1.62%	-4.91%	-0.22%	-0.46%	-3.83%	-1.41%	13.79%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	1.95%	-	-	-	1.53%	1.54%
Cost of Revenue to Revenue	87.98%	88.59%	87.38%	88.53%	87.85%	88.61%	87.45%	86.96%	86.90%	86.39%	85.78%
SG&A Expenses to Revenue	7.59%	6.83%	7.98%	7.85%	8.61%	7.56%	8.85%	9.18%	9.25%	9.89%	9.89%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	8.33%	7.51%	8.75%	8.59%	9.41%	8.35%	10.22%	10.11%	10.83%	11.14%	11.05%
Earnings before Interest and Taxes (EBIT)	34	39	34	27	23	41	17	21	22	19	23
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	42	46	41	34	31	49	24	28	30	27	31
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.80	0.86	0.88	0.81	0.82	1.04	1.17	1.18	1.25	0.00	0.88
Price to Tangible Book Value (P/TBV)	1.24	1.29	1.30	1.19	1.18	1.41	1.60	1.61	1.89	0.00	1.32
Price to Revenue (P/Rev)	0.18	0.20	0.20	0.19	0.20	0.28	0.32	0.34	0.37	0.00	0.27
Price to Earnings (P/E)	7.33	7.91	8.48	8.20	9.27	11.21	13.90	14.21	14.68	0.00	11.81
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	13.65%	12.64%	11.79%	12.20%	10.78%	8.92%	7.20%	7.04%	6.81%	0.00%	8.47%
Enterprise Value to Invested Capital (EV/IC)	0.85	0.89	0.91	0.86	0.86	1.03	1.18	1.19	1.25	0.00	0.88
Enterprise Value to Revenue (EV/Rev)	0.26	0.28	0.27	0.27	0.26	0.31	0.32	0.32	0.37	0.00	0.27
Enterprise Value to EBITDA (EV/EBITDA)	6.14	6.46	6.39	6.30	6.29	7.19	7.95	7.99	8.80	0.00	6.80
Enterprise Value to EBIT (EV/EBIT)	7.62	7.92	7.80	7.67	7.76	8.86	10.06	10.18	11.27	0.00	9.19
Enterprise Value to NOPAT (EV/NOPAT)	10.06	10.68	10.53	10.48	10.48	12.88	14.75	15.11	18.16	0.00	13.07
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	9.02	5.67	3.63	2.83	3.58	0.00	4.96
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	11.45	5.92	3.70	2.73	4.39	0.00	8.23
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.39	0.44	0.35	0.36	0.27	0.18	0.15	0.16	0.16	0.16	0.16
Long-Term Debt to Equity	0.39	0.44	0.35	0.36	0.26	0.17	0.15	0.15	0.15	0.15	0.14
Financial Leverage	0.27	0.29	0.24	0.31	0.28	0.24	0.14	0.14	0.11	0.08	-0.01
Leverage Ratio	2.35	2.39	2.27	2.34	2.24	2.15	2.06	2.10	2.01	1.88	1.90
Compound Leverage Factor	2.22	2.21	2.00	2.04	1.83	2.09	2.14	2.22	2.06	1.95	1.98
Debt to Total Capital	28.30%	30.74%	26.14%	26.71%	21.33%	15.03%	13.38%	13.48%	13.65%	13.61%	13.42%
Short-Term Debt to Total Capital	0.36%	0.40%	0.50%	0.56%	0.71%	0.70%	0.72%	0.74%	1.09%	0.95%	0.92%
Long-Term Debt to Total Capital	27.95%	30.34%	25.64%	26.15%	20.62%	14.33%	12.66%	12.74%	12.56%	12.66%	12.50%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	71.70%	69.26%	73.86%	73.29%	78.67%	84.97%	86.62%	86.52%	86.35%	86.39%	86.58%
Debt to EBITDA	2.11	2.35	1.90	2.02	1.63	1.09	1.06	1.09	1.11	1.29	1.20
Net Debt to EBITDA	1.85	1.94	1.67	1.80	1.35	0.80	-0.10	-0.31	0.00	0.29	-0.06
Long-Term Debt to EBITDA	2.08	2.32	1.86	1.98	1.57	1.04	1.00	1.03	1.02	1.20	1.12
Debt to NOPAT	3.45	3.88	3.13	3.36	2.71	1.95	1.96	2.07	2.29	2.49	2.31
Net Debt to NOPAT	3.02	3.21	2.76	2.99	2.25	1.43	-0.18	-0.59	0.01	0.55	-0.11
Long-Term Debt to NOPAT	3.41	3.83	3.07	3.29	2.62	1.86	1.86	1.95	2.11	2.32	2.15
Altman Z-Score	3.29	3.26	3.55	3.39	3.67	4.12	4.07	3.93	3.88	0.00	3.65
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.00	2.05	2.12	2.11	2.15	2.30	2.20	2.10	2.03	2.11	2.07
Quick Ratio	0.99	1.01	0.97	1.00	1.05	1.16	1.16	1.15	1.07	1.08	1.12
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-199	-219	-184	-139	12	123	234	332	212	161	52
Operating Cash Flow to CapEx	-7,084.65%	-751.45%	2,397.81%	-444.93%	4,040.30%	2,479.37%	6,617.81%	4,310.16%	1,887.58%	-313.63%	4,648.98%
Free Cash Flow to Firm to Interest Expense	-57.72	-43.37	-32.13	-25.06	2.09	36.74	117.04	159.00	100.68	81.79	28.18
Operating Cash Flow to Interest Expense	-14.05	-5.31	9.60	-2.74	16.75	18.82	80.04	26.24	21.26	-3.14	35.98
Operating Cash Flow Less CapEx to Interest Expense	-14.25	-6.02	9.20	-3.36	16.33	18.06	78.83	25.63	20.13	-4.14	35.21
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.96	1.93	1.99	1.89	1.91	1.84	1.84	1.69	1.71	1.74	1.70
Accounts Receivable Turnover	5.42	5.40	5.73	5.11	5.18	4.98	5.43	4.88	5.02	4.99	5.16
Inventory Turnover	5.44	5.01	4.99	4.87	4.92	4.74	4.76	4.50	4.77	4.92	5.12
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	96.03	0.00	0.00	0.00	90.68
Accounts Payable Turnover	4.84	4.73	4.92	4.75	4.93	4.91	5.03	4.47	4.62	4.95	4.69
Days Sales Outstanding (DSO)	67.35	67.54	63.68	71.44	70.48	73.25	67.20	74.73	72.72	73.19	70.73
Days Inventory Outstanding (DIO)	67.16	72.86	73.19	75.02	74.16	77.07	76.69	81.03	76.58	74.14	71.30
Days Payable Outstanding (DPO)	75.42	77.12	74.22	76.82	73.97	74.32	72.54	81.60	78.96	73.72	77.77
Cash Conversion Cycle (CCC)	59.09	63.28	62.65	69.64	70.67	76.00	71.36	74.16	70.34	73.61	64.27
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,113	1,179	1,153	1,199	1,121	1,077	931	883	921	932	895
Invested Capital Turnover	3.61	3.57	3.63	3.38	3.33	3.19	3.32	3.13	3.09	3.01	3.26
Increase / (Decrease) in Invested Capital	225	247	208	159	7.75	-101	-222	-316	-199	-145	-36
Enterprise Value (EV)	951	1,054	1,045	1,030	958	1,113	1,095	1,053	1,155	0.00	791
Market Capitalization	665	738	772	736	753	989	1,109	1,095	1,154	0.00	798
Book Value per Share	$32.83	$34.16	$34.67	$36.36	$36.84	$38.19	$37.51	$37.41	$38.32	$37.83	$38.43
Tangible Book Value per Share	$21.30	$22.66	$23.33	$24.90	$25.62	$28.04	$27.61	$27.53	$25.39	$25.21	$25.79
Total Capital	1,153	1,245	1,190	1,235	1,163	1,122	1,090	1,068	1,066	1,043	1,042
Total Debt	326	383	311	330	248	169	146	144	146	142	140
Total Long-Term Debt	322	378	305	323	240	161	138	136	134	132	130
Net Debt	286	316	274	294	205	124	-13	-41	0.52	31	-6.53
Capital Expenditures (CapEx)	0.68	3.58	2.29	3.43	2.32	2.55	2.42	1.27	2.38	1.97	1.42
Debt-free, Cash-free Net Working Capital (DFCFNWC)	757	821	802	841	772	757	622	558	553	574	542
Debt-free Net Working Capital (DFNWC)	798	887	839	877	815	802	781	743	698	684	688
Net Working Capital (NWC)	794	882	833	870	806	795	773	735	686	674	678
Net Nonoperating Expense (NNE)	1.94	2.30	3.10	1.07	3.98	-11	-0.29	-0.58	-3.94	-1.10	-1.36
Net Nonoperating Obligations (NNO)	286	316	274	294	205	124	-13	-41	0.52	31	-6.53
Total Depreciation and Amortization (D&A)	7.52	7.15	7.17	7.35	7.31	7.36	6.84	6.89	7.57	8.23	7.59
Debt-free, Cash-free Net Working Capital to Revenue	20.94%	21.81%	21.09%	22.20%	20.75%	21.08%	17.97%	17.11%	17.50%	18.98%	18.22%
Debt-free Net Working Capital to Revenue	22.06%	23.58%	22.07%	23.16%	21.90%	22.33%	22.57%	22.80%	22.10%	22.64%	23.13%
Net Working Capital to Revenue	21.95%	23.45%	21.91%	22.98%	21.68%	22.11%	22.34%	22.56%	21.73%	22.31%	22.81%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.95	$1.02	$0.84	$0.76	$0.62	$1.31	$0.51	$0.66	$0.70	$0.72	$0.75
Adjusted Weighted Average Basic Shares Outstanding	25.20M	25.29M	25.20M	25.14M	24.89M	25.04M	25.03M	24.87M	24.15M	23.81M	23.28M
Adjusted Diluted Earnings per Share	$0.94	$1.01	$0.83	$0.76	$0.61	$1.29	$0.50	$0.66	$0.69	$0.70	$0.74
Adjusted Weighted Average Diluted Shares Outstanding	25.45M	25.50M	25.44M	25.36M	25.18M	25.33M	25.44M	25.22M	24.65M	24.22M	23.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	25.25M	25.35M	24.90M	24.84M	24.97M	25.17M	24.71M	24.03M	0.00	23.46M	22.60M
Normalized Net Operating Profit after Tax (NOPAT)	26	28	24	20	19	22	15	16	17	17	17
Normalized NOPAT Margin	2.75%	2.77%	2.75%	2.10%	2.22%	2.48%	2.03%	2.08%	2.16%	2.30%	2.37%
Pre Tax Income Margin	3.42%	3.58%	3.38%	2.48%	2.19%	4.53%	2.39%	3.04%	2.96%	2.64%	3.44%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	9.90	7.75	5.93	4.84	4.19	12.29	8.65	10.31	10.63	9.64	12.65
NOPAT to Interest Expense	7.54	5.54	4.26	3.57	3.48	6.53	6.25	7.44	6.18	8.10	8.75
EBIT Less CapEx to Interest Expense	9.70	7.04	5.53	4.23	3.78	11.53	7.44	9.70	9.50	8.64	11.87
NOPAT Less CapEx to Interest Expense	7.34	4.83	3.86	2.96	3.06	5.77	5.04	6.83	5.05	7.10	7.98
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	19.32%	22.42%	17.43%	0.00%	19.17%	32.72%	55.66%	90.36%	149.35%	152.45%

Frequently Asked Questions About ScanSource's Financials

When does ScanSource's fiscal year end?

According to the most recent income statement we have on file, ScanSource's financial year ends in June. Their financial year 2024 ended on June 30, 2024.

How has ScanSource's net income changed over the last 2 years?

ScanSource's net income appears to be on a downward trend, with a most recent value of $77.06 million in 2024, falling from $88.80 million in 2022. The previous period was $89.81 million in 2023. See ScanSource's forecast for analyst expectations on what’s next for the company.

What is ScanSource's operating income?

ScanSource's total operating income in 2024 was $90.32 million, based on the following breakdown:

Total Gross Profit: $399.05 million
Total Operating Expenses: $308.73 million

How has ScanSource revenue changed over the last 2 years?

Over the last 2 years, ScanSource's total revenue changed from $3.53 billion in 2022 to $3.26 billion in 2024, a change of -7.7%.

How much debt does ScanSource have?

ScanSource's total liabilities were at $854.78 million at the end of 2024, a 26.5% decrease from 2023, and a 24.4% decrease since 2022.

How much cash does ScanSource have?

In the past 2 years, ScanSource's cash and equivalents has ranged from $36.18 million in 2023 to $185.46 million in 2024, and is currently $185.46 million as of their latest financial filing in 2024.

How has ScanSource's book value per share changed over the last 2 years?

Over the last 2 years, ScanSource's book value per share changed from 31.96 in 2022 to 37.41 in 2024, a change of 17.0%.

Related Companies

This page (NASDAQ:SCSC) was last updated on 6/13/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ScanSource (SCSC) Financials

Frequently Asked Questions About ScanSource's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

ScanSource (SCSC) Financials

Annual Income Statements for ScanSource

Quarterly Income Statements for ScanSource

Annual Cash Flow Statements for ScanSource

Quarterly Cash Flow Statements for ScanSource

Annual Balance Sheets for ScanSource

Quarterly Balance Sheets for ScanSource

Annual Metrics And Ratios for ScanSource

Quarterly Metrics And Ratios for ScanSource

Frequently Asked Questions About ScanSource's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools